why choose us

First received: July 30, 2022

Clinical Trial: Treatment of Metastatic Cancer in Terminally Diagnosed Patients

Condition: Metastatic Cancer

Study Type: Expanded Access


Official Title: Not Provided

Brief Summary: The objective is to provide terminally diagnosed patients with a last line of treatment while improving overall quality of life. Tempol can be added to any chemotherapy regimen to potentially reduce side effects and overcome chemoresistance.

Read more